Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 241 to 243 of 243 entries
Sorted by: Best Match Show Resources per page
Deep Learning to Automate Reference-Free Image Quality Assessment of Whole-Heart MR Images.

Radiology. Artificial intelligence

Piccini D, Demesmaeker R, Heerfordt J, Yerly J, Di Sopra L, Masci PG, Schwitter J, Van De Ville D, Richiardi J, Kober T, Stuber M.
PMID: 33937825
Radiol Artif Intell. 2020 May 27;2(3):e190123. doi: 10.1148/ryai.2020190123. eCollection 2020 May.

PURPOSE: To develop and characterize an algorithm that mimics human expert visual assessment to quantitatively determine the quality of three-dimensional (3D) whole-heart MR images.MATERIALS AND METHODS: In this study, 3D whole-heart cardiac MRI scans from 424 participants (average age,...

Cite
Piccini D, Demesmaeker R, Heerfordt J, et al. Deep Learning to Automate Reference-Free Image Quality Assessment of Whole-Heart MR Images. Radiol Artif Intell. 2020;2(3):e190123doi: 10.1148/ryai.2020190123.
Piccini, D., Demesmaeker, R., Heerfordt, J., Yerly, J., Di Sopra, L., Masci, P. G., Schwitter, J., Van De Ville, D., Richiardi, J., Kober, T., & Stuber, M. (2020). Deep Learning to Automate Reference-Free Image Quality Assessment of Whole-Heart MR Images. Radiology. Artificial intelligence, 2(3), e190123. https://doi.org/10.1148/ryai.2020190123
Piccini, Davide, et al. "Deep Learning to Automate Reference-Free Image Quality Assessment of Whole-Heart MR Images." Radiology. Artificial intelligence vol. 2,3 (2020): e190123. doi: https://doi.org/10.1148/ryai.2020190123
Piccini D, Demesmaeker R, Heerfordt J, Yerly J, Di Sopra L, Masci PG, Schwitter J, Van De Ville D, Richiardi J, Kober T, Stuber M. Deep Learning to Automate Reference-Free Image Quality Assessment of Whole-Heart MR Images. Radiol Artif Intell. 2020 May 27;2(3):e190123. doi: 10.1148/ryai.2020190123. eCollection 2020 May. PMID: 33937825; PMCID: PMC8082371.
Copy Download .nbib Format: NLM
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.

Nature

Andreano E, Paciello I, Piccini G, Manganaro N, Pileri P, Hyseni I, Leonardi M, Pantano E, Abbiento V, Benincasa L, Giglioli G, De Santi C, Fabbiani M, Rancan I, Tumbarello M, Montagnani F, Sala C, Montomoli E, Rappuoli R.
PMID: 34670266
Nature. 2021 Dec;600(7889):530-535. doi: 10.1038/s41586-021-04117-7. Epub 2021 Oct 20.

The emergence of SARS-CoV-2 variants is jeopardizing the effectiveness of current vaccines and limiting the application of monoclonal antibody-based therapy for COVID-19 (refs.

Cite
Andreano E, Paciello I, Piccini G, et al. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature. 2021;600(7889):530-535doi: 10.1038/s41586-021-04117-7.
Andreano, E., Paciello, I., Piccini, G., Manganaro, N., Pileri, P., Hyseni, I., Leonardi, M., Pantano, E., Abbiento, V., Benincasa, L., Giglioli, G., De Santi, C., Fabbiani, M., Rancan, I., Tumbarello, M., Montagnani, F., Sala, C., Montomoli, E., & Rappuoli, R. (2021). Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature, 600(7889), 530-535. https://doi.org/10.1038/s41586-021-04117-7
Andreano, Emanuele, et al. "Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants." Nature vol. 600,7889 (2021): 530-535. doi: https://doi.org/10.1038/s41586-021-04117-7
Andreano E, Paciello I, Piccini G, Manganaro N, Pileri P, Hyseni I, Leonardi M, Pantano E, Abbiento V, Benincasa L, Giglioli G, De Santi C, Fabbiani M, Rancan I, Tumbarello M, Montagnani F, Sala C, Montomoli E, Rappuoli R. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature. 2021 Dec;600(7889):530-535. doi: 10.1038/s41586-021-04117-7. Epub 2021 Oct 20. PMID: 34670266.
Copy Download .nbib Format: NLM
Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy.

Circulation. Cardiovascular interventions

Fanaroff AC, Li S, Marquis-Gravel G, Giri J, Lopes RD, Piccini JP, Wang TY.
PMID: 34932388
Circ Cardiovasc Interv. 2021 Dec;14(12):e011232. doi: 10.1161/CIRCINTERVENTIONS.121.011232. Epub 2021 Dec 21.

BACKGROUND: Older adults with atrial fibrillation (AF) are often treated with the shortest possible duration of antiplatelet/anticoagulant therapy after myocardial infarction (MI) or percutaneous coronary intervention (PCI) due to concern for bleeding. However, the risk of recurrent MI or...

Cite
Fanaroff AC, Li S, Marquis-Gravel G, et al. Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy. Circ Cardiovasc Interv. 2021;14(12):e011232doi: 10.1161/CIRCINTERVENTIONS.121.011232.
Fanaroff, A. C., Li, S., Marquis-Gravel, G., Giri, J., Lopes, R. D., Piccini, J. P., & Wang, T. Y. (2021). Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy. Circulation. Cardiovascular interventions, 14(12), e011232. https://doi.org/10.1161/CIRCINTERVENTIONS.121.011232
Fanaroff, Alexander C, et al. "Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy." Circulation. Cardiovascular interventions vol. 14,12 (2021): e011232. doi: https://doi.org/10.1161/CIRCINTERVENTIONS.121.011232
Fanaroff AC, Li S, Marquis-Gravel G, Giri J, Lopes RD, Piccini JP, Wang TY. Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy. Circ Cardiovasc Interv. 2021 Dec;14(12):e011232. doi: 10.1161/CIRCINTERVENTIONS.121.011232. Epub 2021 Dec 21. PMID: 34932388.
Copy Download .nbib Format: NLM
Showing 241 to 243 of 243 entries